Edition:
India

Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

371.50INR
22 Jan 2018
Change (% chg)

Rs6.05 (+1.66%)
Prev Close
Rs365.45
Open
Rs366.90
Day's High
Rs371.50
Day's Low
Rs366.15
Volume
112,575
Avg. Vol
148,163
52-wk High
Rs425.70
52-wk Low
Rs291.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 43.10 3.578
Jun 31.32 -1.647
FY 2017 Mar '17 44.11 -1.064
Dec 126.20 -3.853
Sep 17.92 -1.271
Jun 13.55 -0.840
FY 2016 Mar '16 182.38 -1.659
Dec 256.68 -16.928
Sep 1,972.88 2.199
Jun 1,870.79 3.526
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.98 46.03
P/E Low - Last 5 Yrs. -- 23.80 24.39
Beta 0.82 0.90 0.89
Price to Sales (TTM) 102.07 3.98 5.45
Price to Book (MRQ) -- 4.82 5.38
Price to Tangible Book (MRQ) -- 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions -- 1.23 2.16

Dividends

  Company industry sector
Dividend Yield 0.55 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) -- 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 131.11 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago 137.06 4.69 5.44
Sales - 5 Yr. Growth Rate -- 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -95.99 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago 68.15 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.88 2.97
LT Debt to Equity (MRQ) -- 9.81 12.10
Total Debt to Equity (MRQ) -- 13.80 16.38
Interest Coverage (TTM) -1.48 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 72.14 55.13 54.76
Gross Margin - 5 Yr. Avg. -- 52.41 52.45
EBITD Margin (TTM) -358.32 -- --
EBITD - 5 Yr. Avg -- 18.54 15.33
Operating Margin (TTM) -375.91 14.40 7.60
Operating Margin - 5 Yr. Avg. -- 14.46 10.79
Pre-Tax Margin (TTM) -336.83 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. -- 14.77 11.19
Net Profit Margin (TTM) -219.89 11.09 4.70
Net Profit Margin - 5 Yr. Avg. -- 11.11 7.50
Effective Tax Rate (TTM) -- 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -- 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 118,782 948,195,516 855,725,045
Net Income/Employee (TTM) -261,187 111,561,295 100,665,187
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.34
Asset Turnover (TTM) -- 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.41 10.97
Return on Assets - 5 Yr. Avg. -- 12.98 12.39
Return on Investment (TTM) -- 14.84 14.40
Return on Investment - 5 Yr. Avg. -- 16.97 16.20
Return on Equity (TTM) -- 16.32 16.09
Return on Equity - 5 Yr. Avg. -- 18.05 17.53
  1 Year 3 Year 5 Year
Sales % -80.83 -- --
EPS (TTM) % 63.72 -- --
Dividend % 0.00 -- --
Note: Units in Millions of US Dollars

Performance for Claris Lifesciences Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.19 -2.58 99 25
13 Week 0.70 -0.73 99 36
26 Week 10.79 3.45 99 31
52 Week 30.38 15.18 99 12
YTD 13.86 -4.71 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.89%
# of Holders: 9
Total Shares Held: 9,218,935
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.